[In vitro anti-myeloma effects induced by myeloma idiotype-protein pulsed dendritic cell vaccine]

Dendritic cells in clinical trials for multiple myeloma

Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy

Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma

Accomplishments and perspectives of immunological interventions in lymphoproliferative disorders

Dendritic cell-based immunotherapy in multiple myeloma

Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells

Dendritic cell-based immunotherapy for the treatment of hematological malignancies

Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines